跳至主要内容
临床试验/NCT03879096
NCT03879096已完成不适用

Clinical and Functional Variables in the Assessment of Oncology Patient

University of Malaga1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2016年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
120
试验地点
1
主要终点
Change from Cancer-Related Fatigue (CRF)

研究概览

简要总结

The aim is to analyse the effect of a Therapeutic Exercise and Education programme in several clinical and functional outcomes in cancer patient and survivors

详细描述

In the oncology field, both patients and survivors have to face several symptoms, like cancer-related fatigue or pain. Cancer patients also have affected quality of life, lower levels of function and they are at higher risk of weight gain following diagnosis. Given the risk of obesity, both exercise and diet play a key role in recovery from cancer.

Hence, the aim of this study is to show the effect of a Therapeutic Exercise and Education programme (TEEP) in clinical and functional, including practical nutritional education in other clinical and functional secondary outcomes in cancer patients and survivors.

Variables included are: body composition, mediterranean-diet adherence, quality of life (QoL) and functional outcomes (limb functionality, physical activity, physical function and handgrip strength). Furthermore, laboratory variables like muscle thickness (ecography) and muscle activity (electromyography) were included.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • In the case of survivors: Patient who had been surgically treated for their primary tumour with no evidence of recurrence at the time of recruitment. The inclusion of patients undergoing hormonal treatment radiotherapy or antiHER therapy will be allowed.
  • In the case of cancer patients: patient who had been dignosed by cancer.
  • In both cases, all participants have to maintain the minimum physical function to perform exercise in group.

排除标准

  • Patients were excluded if they had suffered any cardiovascular event defined as stable or unstable angor, acute pulmonary edema, cardiac rhythm disorders, or syncope of cause not affiliated in the year prior to inclusion

结局指标

主要结局

Change from Cancer-Related Fatigue (CRF)

时间窗: Prior and after intervention, an average of 3 months

The Spanish version of the Piper Fatigue Scale-Revised (PFS-R) will be used

Change from Upper limb functionality (%)

时间窗: prior and after intervention, an average of 3 months

the Spanish version of Upper Limb Functional Index (ULFI) questionnaire will be filled

Change from Lower limb functionality(%)

时间窗: prior and after intervention, an average of 3 months

the Spanish version of the Lower Limb Functional Index (LLFI) questionnaire will be filled

Change from Functional capacity

时间窗: prior and after intervention, an average of 3 months

It will be tested by 30-second Sit-To-Stand Test (30-STS), number of repetitions completed.

次要结局

  • Body Composition(prior and after intervention, an average of 3 months)
  • Change fromQuality of life (self-reported questionnaire)(prior and after intervention, an average of 3 months)
  • Change from specific Breast Cancer Quality of life (self-reported questionnaire)(prior and after intervention, an average of 3 months)
  • Change from Grip Strength (dynamometry)(prior and after intervention, an average of 3 months)
  • Change from fat mass(prior and after intervention, an average of 3 months)
  • Change from lean mass(prior and after intervention, an average of 3 months)
  • Change from water balance(prior and after intervention, an average of 3 months)
  • Change from Muscle thickness(prior and after intervention, an average of 3 months)
  • Change from Basal Metabolism(prior and after intervention, an average of 3 months)
  • Change from Body Mass Index(prior and after intervention, an average of 3 months)
  • Change from Physical activity (METS)(prior and after intervention, an average of 3 months)
  • Change from Handgrip Strength (Kg)(prior and after intervention, an average of 3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Antonio I Cuesta-Vargas

Principal Researcher of CTS631 University of Malaga

University of Malaga

研究点 (1)

Loading locations...

相似试验